Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Canobbio

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reviews|March 1, 1996
Medical treatment of advanced renal cell carcinoma: present options and future directionsL Canobbio, L Miglietta, F Boccardo
Anticancer Research|November 1, 1995
Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levelsL Canobbio, D Cannata, L Miglietta, et al.
Oncology|January 1, 1986
Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combinationT Fassio, L Canobbio, G Gasparini, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1985
Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancerA Ardizzoni, P Pronzato, L Canobbio, et al.
Oncology Reports|May 25, 2011
Use of long-acting somatostatin analog, lanreotide, in neuroendocrine tumorsL Canobbio, D Cannata, L Miglietta, et al.
Journal of the National Cancer Institute|March 1, 1987
Role of administration route in the therapeutic efficacy of doxifluridineF Trave, L Canobbio, J L Au, et al.
Cancer|February 1, 1992
Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot studyL Canobbio, F Boccardo, D Cannata, et al.
Oncology|January 1, 1990
Role of blood groups as prognostic factors in primary breast cancerM Costantini, T Fassio, L Canobbio, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II studyL Miglietta, L Canobbio, C Granetto, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancerF Boccardo, L Canobbio, M Resasco, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|March 1, 1996
Medical treatment of advanced renal cell carcinoma: present options and future directionsL Canobbio, L Miglietta, F Boccardo
Anticancer Research|November 1, 1995
Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levelsL Canobbio, D Cannata, L Miglietta, et al.
Oncology|January 1, 1986
Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combinationT Fassio, L Canobbio, G Gasparini, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1985
Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancerA Ardizzoni, P Pronzato, L Canobbio, et al.
Oncology Reports|May 25, 2011
Use of long-acting somatostatin analog, lanreotide, in neuroendocrine tumorsL Canobbio, D Cannata, L Miglietta, et al.
Journal of the National Cancer Institute|March 1, 1987
Role of administration route in the therapeutic efficacy of doxifluridineF Trave, L Canobbio, J L Au, et al.
Cancer|February 1, 1992
Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot studyL Canobbio, F Boccardo, D Cannata, et al.
Oncology|January 1, 1990
Role of blood groups as prognostic factors in primary breast cancerM Costantini, T Fassio, L Canobbio, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II studyL Miglietta, L Canobbio, C Granetto, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancerF Boccardo, L Canobbio, M Resasco, et al.
Pageof 4